Tongji Hospital Wuhan IVF Success Rate: Real Data & Influencing Factors
The IVF success rate at the Reproductive Medicine Center of Tongji Hospital Wuhan is influenced by age, embryo quality, and endometrial receptivity. The live birth rate for women under 35 is approximately 55%-60%, placing the center at a leading national level. This article analyzes the true range of success rates and key determining factors based on clinical data and industry consensus.
Start of main content
In outpatient clinics, we often encounter questions like: "Doctor, what is the actual IVF success rate at Tongji Hospital? I am 35 years old, with an AMH of 1.8, had one ectopic pregnancy surgery, and failed one ovulation induction cycle at another hospital." Behind such questions lies anxiety about the "success rate" number and a psychological desire for certainty by choosing a hospital with high success rates. However, success rate is a population-based statistical concept. For an individual, there are only two outcomes: "success" or "failure." Based on a real clinical perspective, this article breaks down the success rate data, influencing factors, and key information patients need to know before seeking treatment at the Reproductive Medicine Center of Tongji Hospital Wuhan.
1. Direct Answer: What is the Success Rate Range at Tongji Hospital?
The Reproductive Medicine Center of Tongji Hospital Wuhan (affiliated with Tongji Medical College, HUST) is one of the first institutions in Central China approved by the National Health Commission to perform assisted reproductive technology. According to the center's recent publicly available clinical data and academic exchange information within the field, its overall live birth rate places it in the top tier nationally, on par with top centers like Peking University Third Hospital and Shanghai Ninth People's Hospital. Specific data stratified by age is as follows:
| Female Age | Live Birth Rate per Single Transfer (Reference Range) | Notes |
|---|---|---|
| < 35 years | 55% – 60% | Frozen embryo cycles slightly higher than fresh cycles |
| 35 – 38 years | 40% – 50% | Embryo chromosomal abnormality rate begins to rise |
| 38 – 40 years | 30% – 40% | Miscarriage rate increases to over 30% |
| 40 – 42 years | 15% – 25% | Embryo aneuploidy rate > 60% |
| > 42 years | < 10% | Consider evaluating egg donation options |
2. How Doctors View Success Rates: The Core Dimension is Patient Stratification
As reproductive medicine specialists, when evaluating a hospital's success rate, we focus not on "rankings" but on detailed data stratified by patient characteristics. Tongji Hospital's advantages are evident in three areas:
- Multidisciplinary Team (MDT): Collaboration between Obstetrics & Gynecology, Genetics, Endocrinology, Urology, and Reproductive Immunology allows for managing complex cases such as recurrent implantation failure, recurrent miscarriage, and genetic disorders.
- Embryology Lab Quality Control: Laboratory indicators such as blastocyst formation rate, good-quality embryo rate, and freeze-thaw survival rate are among the best nationally. Lab stability is the cornerstone of success rates.
- Clinical Pathways for Difficult Cases: Standardized diagnostic and treatment protocols exist for conditions like Poor Ovarian Response (POR), Recurrent Implantation Failure (RIF), and uterine pathologies, rather than a "one-size-fits-all" approach.
However, doctors must be honest: A high success rate does not mean "success is guaranteed just by coming to Tongji." For patients over 38 with significantly diminished ovarian reserve, the live birth rate will not be very high at any center. The doctor's decision-making logic is: first, comprehensively assess ovarian reserve, uterine conditions, and overall health; then formulate an individualized plan; and dynamically adjust during the cycle.
3. Differences Across Age Groups: Age is the Biggest Variable
Age is the most critical factor affecting IVF success rates, bar none. The reason is: Both the quantity and quality of a woman's eggs decline irreversibly with age.
| Age Group | Ovarian Reserve Characteristics | Reference Live Birth Rate per Single Transfer | Main Risks |
|---|---|---|---|
| < 35 years | Adequate reserve, high oocyte yield, high rate of chromosomally normal embryos | 55% – 60% | Multiple pregnancy, OHSS (Ovarian Hyperstimulation Syndrome) |
| 35 – 38 years | Reserve begins to decline, fewer oocytes retrieved | 40% – 50% | Embryo chromosomal abnormality rate rises to ~30% |
| 38 – 40 years | Significantly diminished reserve, decreased egg quality | 30% – 40% | Miscarriage rate > 30%, live birth rate declines rapidly |
| 40 – 42 years | Severely diminished reserve, often ≤3 oocytes retrieved | 15% – 25% | Embryo aneuploidy rate > 60%, PGT-A recommended |
| > 42 years | Very low reserve or may need egg donation evaluation | < 10% | Very low live birth rate; consider egg donation or adoption early |
Special attention: For patients over 40, even at a top-tier center like Tongji, the live birth rate will not be significantly higher than the industry average. This is because the embryo chromosomal abnormality rate is primarily determined by age, and hospitals cannot change biological laws. For this group, the doctor's advice is usually: do not delay, complete the evaluation as soon as possible, and consider PGT-A screening or egg donation if necessary.
4. Most Overlooked Details: Hidden Factors Affecting Success Rates
In clinical practice, the following details are often overlooked by patients but have a substantial impact on success rates:
- Dynamic Relationship between AMH and Antral Follicle Count (AFC): AMH reflects the quantity of egg reserve, not quality. Low AMH but good egg quality (e.g., in younger patients) can still yield a good success rate. Normal AMH but poor egg quality (e.g., advanced age, endometriosis) may lead to unsatisfactory outcomes.
- Endometrial Receptivity: Many patients focus excessively on eggs and embryos while ignoring uterine pathologies. Chronic endometritis (CD138+), endometrial polyps, intrauterine adhesions, and thin endometrium are common causes of recurrent implantation failure. Tongji Hospital routinely recommends hysteroscopy + ERA (Endometrial Receptivity Analysis) for RIF patients.
- Vitamin D Levels: The Tongji Reproductive Center has included Vitamin D testing as routine screening. Vitamin D deficiency (< 20 ng/mL) is associated with recurrent implantation failure and miscarriage; supplementation may improve outcomes.
- Male Sperm DNA Fragmentation Index (DFI): Even if sperm concentration and motility are normal, a DFI > 30% can affect embryo development and implantation. Elevated DFI is linked to oxidative stress, varicocele, smoking, etc. Antioxidant therapy or ICSI may partially help.
5. Common Pitfalls: Practices That May Lower Success Rates
Based on real outpatient observations, the following behaviors can significantly impact treatment outcomes:
- Blindly Pursuing Transferring Multiple Blastocysts: Transferring 2 blastocysts does not increase the live birth rate but raises the risk of twin pregnancy by 3–4 times. The preterm birth rate for twins is 6 times higher than for singletons, and the risk of neonatal complications (cerebral palsy, respiratory distress, etc.) increases substantially. Tongji Hospital strictly adheres to the principle of single blastocyst transfer, especially for patients with uterine anomalies or a scarred uterus.
- Repeatedly Requesting Changes to the Ovarian Stimulation Protocol: There is no "absolute best" protocol, only the "most suitable" one. Doctors adjust protocols dynamically based on the patient's ovarian response. Frequently changing protocols prevents the doctor from gaining experience with the medication, potentially lowering success rates.
- Ignoring Weight Management: For patients with a BMI > 28, the live birth rate decreases by approximately 30%. The Tongji Reproductive Center advises obese patients to lose weight before starting a cycle. However, some patients, eager for quick results, skip this step and proceed directly to stimulation, resulting in fewer oocytes retrieved and higher cancellation rates.
- Overinterpreting Online Success Rate Data: Different hospitals report "success rates" using different definitions (clinical pregnancy rate vs. live birth rate, fresh vs. frozen embryos, per transfer vs. cumulative live birth rate), making direct comparisons meaningless. It is recommended that patients ask their doctor directly during the initial consultation: "Based on my age and test results, what is the estimated live birth rate per single transfer?"
6. Timeline: How Long Does a Complete Cycle Take?
From the initial consultation to pregnancy confirmation, a complete IVF cycle typically takes 2–3 months. The specific timeline is as follows:
If a frozen embryo transfer is planned, there may be an interval of 1–2 menstrual cycles to prepare the endometrium or wait for PGT results. For patients of advanced age or with diminished ovarian reserve, doctors might recommend double oocyte retrieval (follicular and luteal phase) to accumulate more embryos, which can extend the cycle by 1–2 months.
7. Interpreting Test Results: What These Values Mean
Among the routine pre-cycle tests at Tongji Hospital, the following indicators are most critical:
Essential Tests for Women
| Test | Reference Range | Clinical Significance |
|---|---|---|
| FSH (Day 2–4 of menstruation) | < 10 IU/L | > 10 suggests diminished ovarian reserve; > 15 suggests decreased ovarian function |
| AMH (any time) | > 1.1 ng/mL | < 1.1 suggests diminished ovarian reserve; < 0.5 suggests severe decline |
| Antral Follicle Count (AFC) | 5 – 10 (both ovaries combined) | < 5 suggests insufficient ovarian reserve, potentially low oocyte yield |
| TSH (Thyroid function) | < 4.0 mIU/L | > 4.0 requires treatment to normalize before starting the cycle |
| Saline Infusion Sonography (SIS) | Normal uterine cavity shape | Rules out space-occupying lesions like polyps, adhesions, fibroids |
Essential Tests for Men
| Test | Reference Range | Clinical Significance |
|---|---|---|
| Semen Analysis + Morphology | Concentration ≥ 15×10⁶/mL, Motility ≥ 32% | Values below reference require further evaluation of the cause |
| Sperm DNA Fragmentation Index (DFI) | < 30% | > 30% may affect embryo development and implantation; antioxidant therapy or ICSI recommended |
8. Managing Special Situations: Recurrent Implantation Failure and Poor Ovarian Response
Recurrent Implantation Failure (RIF)
Defined as failure of implantation after transferring good-quality embryos 3 or more times. Tongji Hospital's diagnostic and treatment pathway includes:
- Hysteroscopy to investigate endometrial pathology (chronic endometritis, adhesions)
- Endometrial Receptivity Analysis (ERA) – to determine the optimal transfer timing
- Chronic endometritis testing (CD138+ immunohistochemistry)
- Immunological factor screening (antiphospholipid antibodies, NK cell activity, T cell subsets)
- Embryo PGT-A screening for chromosomal aneuploidy
Poor Ovarian Response (POR)
Defined as retrieval of ≤ 3 oocytes. Management strategies include:
- Individualized stimulation protocols (PPOS, mild stimulation, natural cycle)
- Growth hormone pretreatment (used continuously for 6–8 weeks)
- Double oocyte retrieval (follicular and luteal phase) to increase embryo numbers
- Consider egg donation if necessary
9. Risk Reminders
No assisted reproductive treatment can guarantee 100% success. Before deciding to start a cycle, patients are advised to fully understand the following risks:
- Ovarian Hyperstimulation Syndrome (OHSS): Incidence is about 1%–3%, mainly presenting as bloating, abdominal pain, nausea, and decreased urine output. Tongji Hospital routinely uses GnRH antagonist protocols plus elective embryo freezing for high-risk OHSS patients (high AMH, PCOS, young, lean body type), significantly reducing the risk.
- Multiple Pregnancy: With single blastocyst transfer, the multiple pregnancy rate is about 2%–5%; with double blastocyst transfer, it can be as high as 30%–40%. The risk of obstetric complications (preterm birth, preeclampsia, gestational diabetes) is significantly increased in multiple pregnancies.
- Embryo Culture Failure: Fertilization failure, embryo developmental arrest, or having no transferable embryos can occur after egg retrieval. The incidence increases with age; about 15%–25% of patients over 40 may face a situation with no embryos to transfer.
- Psychological and Financial Stress: The cost of one complete cycle (including tests, stimulation, egg retrieval, transfer) is approximately 35,000–50,000 RMB, excluding additional PGT costs. If multiple cycles fail, the financial burden and psychological stress can increase significantly.
0 comments